Cardiovascular disease (CVD) constitutes a heterogeneous ensemble of pathological conditions impacting the heart and vasculature, encompassing a multitude of disorders within the cardiovascular apparatus. Among these, heart failure (HF) emerges as a particularly pervasive and deleterious malady, afflicting individuals across all demographic strata. HF ensues when the myocardium is incapable of propelling blood with requisite efficacy, precipitating manifestations such as dyspnea, lassitude, and fluid retention. This insidious, progressive affliction substantially exacerbates mortality risk, particularly in the presence of concomitant comorbidities. For clinicians, prognosticating survival probabilities for HF patients remains a formidable challenge, necessitating the deployment of computational methodologies to enable nuanced and expeditious therapeutic determinations. Machine learning (ML) algorithms proffer an avant-garde paradigm, empowering cardiologists to devise bespoke treatment regimens derived from pertinent clinical data. This investigation endeavors to construct an interpretable ML-driven prognostic framework for HF survival analysis. Leveraging the UCI HF dataset, comprising clinical records of numerous patients, we undertook rigorous data curation and preprocessing to refine data integrity and elucidate distributional properties. Essential procedures, including meticulous data cleaning and feature engineering, were employed to bolster predictive precision. The study assessed an array of ML algorithms - Naïve Bayes (NB), Logistic Regression (LR), Random Forest (RF), XGBoost (XGB), and LightGBM - while employing hyperparameter optimization and overfitting mitigation strategies to enhance model robustness. Evaluation metrics such as precision, recall, F1-score, and the area under the receiver operating characteristic curve (AUC) were prioritized to furnish a comprehensive appraisal, transcending reliance on accuracy alone. Empirical findings revealed the preeminence of the Random Forest (RF) classifier, which achieved an accuracy of 87.77% and an AUC of 94.36% in forecasting HF patient survival. These outcomes illuminate the transformative potential of ML methodologies in refining clinical prognostication, equipping cardiologists with actionable intelligence to enact prompt and informed clinical interventions, thereby augmenting patient care and prognostic precision